Abstract

BackgroundBK virus allograft nephropathy is a serious complication after kidney transplantation, and the effect of pre-emptive intervention for high-level BK viruria has been verified, but protocols after kidney transplantation for early identification of high-level viruria are lacking.MethodsThis was a single-center study. The clinical data of the kidney transplant recipients and their donors in our center from January 1, 2015 to December 31, 2018, were collected. The patients were divided into the high-level BK viruria group (Group A) and a non-high-level BK viruria group (Group B) according to the qPCR results of BK virus DNA loads in urine samples. Significant variables were screened out by univariate analysis, and then the results were incorporated into a multivariate logistic regression model to analyze the independent risk factors for high-level BK viruria.ResultsA total of 262 recipients were included in the study. The incidence of high-level BK viruria was 13.4% (n = 35), and the median time of detection was 181 (range 91–1119) days. Univariate analysis showed that donor type (chi^{2} = 21.770, P < 0.001), history of ATG/ATG-F application (chi^{2} = 4.543, P = 0.033), acute rejection (AR) (chi^{2} = 8.313, P = 0.004) and delayed graft function (DGF) (chi^{2} = 21.170, P < 0.001) were related to high-level BK viruria. After the inclusion of the multivariate logistic regression model, the results showed deceased brain and cardiac donors (P = 0.032, OR = 3.927, 95% CI 1.122–13.746), AR (P = 0.022, OR = 4.709, 95% CI 1.253–17.697) and DGF (P = 0.001, OR = 6.682, 95% CI 2.288–19.518).ConclusionsDonation by deceased brain and cardiac patients, history of AR and DGF were independent risk factors for high-level BK viruria after kidney transplantation.

Highlights

  • BK virus allograft nephropathy (BKVAN) is a severe disease caused by BK virus (BKV) infection or reactivation, which often impairs kidney function irreversibly and is more common in kidney transplant recipients [1]

  • This study summarized the incidence of high-level BK viruria from 2015 to 2018 and analyzed its risk factors to identify patients at an early stage and provide treatment to prevent the occurrence of BKVAN

  • Demographics and clinical characteristics of recipients and donors A total of 262 patients were included in this study, including 35 in group A and 227 in group B

Read more

Summary

Introduction

BK virus allograft nephropathy (BKVAN) is a severe disease caused by BK virus (BKV) infection or reactivation, which often impairs kidney function irreversibly and is more common in kidney transplant recipients [1]. The usual progression of infection begins with BK viruria and progresses to BK viremia, eventually leading to BKVAN. The importance of prevention is underscored by the lack. This study summarized the incidence of high-level BK viruria from 2015 to 2018 and analyzed its risk factors to identify patients at an early stage and provide treatment to prevent the occurrence of BKVAN. BK virus allograft nephropathy is a serious complication after kidney transplantation, and the effect of pre-emptive intervention for high-level BK viruria has been verified, but protocols after kidney transplantation for early identification of high-level viruria are lacking

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call